A prospective, open, randomized, phase-II study of a therapeutic cancer vaccine (L-BLP25, Stimuvax) in the pre-operative treatment of women with primary breast cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Tecemotide (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Letrozole
- Indications Early breast cancer
- Focus Therapeutic Use
- 05 Jun 2018 Results assessing utility of Ki67 measurements in predicting clinical outcomes presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 09 Dec 2017 Results assessing efficacy presented at the 40th Annual San Antonio Breast Cancer Symposium.
- 12 Sep 2017 Results (n=385) of quality-of-life analysis, presented at the 42nd European Society for Medical Oncology Congress.